X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/manufacturing/belgiums-ucb-pharma-hit-form-483-following-inspection
https://www.pharmacompass.com/pdf/news/ucb-pharma-sa-on-fda-import-list-49365.pdf
https://www.fiercebiotech.com/cro/veeva-deal-ucb-leverage-digital-tools-help-patient-trial-experiences
https://www.prnewswire.com/news-releases/ucb-and-ariceum-therapeutics-sign-a-strategic-research-collaboration-to-discover-new-modalities-for-the-treatment-of-immune-related-diseases-and-cancer-301821046.html
https://www.prnewswire.com/news-releases/huma-and-ucb-partner-to-provide-digital-health-solution-to-improve-management-of-the-rare-disease-myasthenia-gravis-301806856.html
https://www.prnewswire.com/news-releases/ucb-showcases-strength-and-depth-of-neurology-portfolio-at-75th-american-academy-of-neurology-aan-annual-meeting-301802240.html
https://www.fiercepharma.com/pharma/appeals-court-shoots-down-ucbs-neupro-patch-patent-allowing-actavis-and-mylan-generics
https://www.fiercepharma.com/pharma/new-skin-disease-battle-next-gen-biologics-doctors-see-novartis-cosentyx-underdog
https://www.prnewswire.com/news-releases/bimekizumab-phase-3-data-in-hidradenitis-suppurativa-show-clinically-meaningful-deep-and-maintained-response-over-48-weeks-301775572.html
https://www.prnewswire.com/news-releases/ucb-to-present-eight-bimekizumab-abstracts-at-aad-2023-with-results-from-studies-in-psoriasis-psoriatic-arthritis-and-hidradenitis-suppurativa-301773981.html
Market Place
Share 
